» Articles » PMID: 17034021

Schizophrenic-like Neurocognitive Deficits in Children and Adolescents with 22q11 Deletion Syndrome

Overview
Date 2006 Oct 13
PMID 17034021
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

22q11.2 Deletion Syndrome (22q11DS) is the most common genetic microdeletion syndrome affecting humans. The syndrome is associated with general cognitive impairments and specific deficits in visual-spatial ability, non-verbal reasoning, and planning skills. 22q11DS is also associated with behavioral and psychiatric abnormalities, including a markedly elevated risk for schizophrenia. Research findings indicate that people with schizophrenia, as well as those identified as schizoptypic, show specific cognitive deficits in the areas of sustained attention, executive functioning, and verbal working memory. The present study examined such schizophrenic-like cognitive deficits in children and adolescents with 22q11DS (n = 26) and controls (n = 25) using a cross-sectional design. As hypothesized, 22q11DS participants exhibited deficits in intelligence, achievement, sustained attention, executive functioning, and verbal working memory compared to controls. Furthermore, deficits in attention and executive functioning were more pronounced in the 22q11DS sample relative to general cognitive impairment. These findings suggest that the same pattern of neuropsychological impairment seen in patients with schizophrenia is present in non-psychotic children identified as at-risk for the development of schizophrenia based on a known genetic risk marker.

Citing Articles

Neurocognitive dysfunctions in childhood-onset schizophrenia: A systematic review.

Armita A, Guivarch J, Dor E, Laure G, Zeghari R, Gindt M Schizophr Res Cogn. 2025; 40:100342.

PMID: 39867751 PMC: 11759536. DOI: 10.1016/j.scog.2024.100342.


Spelling deficits in children with intellectual disabilities: Evidence from a regular orthography.

Di Blasi F, Vizzi F, Stimoli M, Buono S, Iaia M, Zoccolotti P Front Psychol. 2023; 13:1065525.

PMID: 36733855 PMC: 9887300. DOI: 10.3389/fpsyg.2022.1065525.


Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial.

Latreche C, Maeder J, Mancini V, Schneider M, Eliez S Front Psychiatry. 2022; 13:972420.

PMID: 36386982 PMC: 9643534. DOI: 10.3389/fpsyt.2022.972420.


Altered developmental trajectories of verbal learning skills in 22q11.2DS: associations with hippocampal development and psychosis.

Latreche C, Maeder J, Mancini V, Bortolin K, Schneider M, Eliez S Psychol Med. 2022; 53(11):4923-4932.

PMID: 35775360 PMC: 10476015. DOI: 10.1017/S0033291722001842.


From Learning to Memory: A Comparison Between Verbal and Non-verbal Skills in 22q11.2 Deletion Syndrome.

Maeder J, Bostelmann M, Schneider M, Bortolin K, Kliegel M, Eliez S Front Psychiatry. 2021; 12:597681.

PMID: 34220562 PMC: 8242156. DOI: 10.3389/fpsyt.2021.597681.